PRELIMINARY PROGRAM

The 2nd EVA (Endo Vascular Access) Meeting is a multidisciplinary meeting focusing on the endovascular management of vascular access. It is a 2-day meeting taking place in Patras University Campus in Greece on June 24-25, 2022. Meeting’s faculty is a multidisciplinary one including nephrologists,interventional nephrologists, vascular surgeons, and interventional radiologists and a multi-national one with speakers from Europe the United States, Middle East, and Asia-Pacific regions. Its aim is to bring doctors with an interest in vascular access management together, discuss the latest updates, innovations and unmet needs in this interesting and demanding field. The meeting will include 19 sessions and 3 live cases from the Interventional Radiology Department of Patras University Hospital. The sessions will include the latest data on trial updates, endoAVF management, guidelines update, a session dedicated to cephalic arch, an out-of-the-box session, innovation on ESKD, vascular access imaging and central venous catheters. Additionally, the program will include two controversy sessions on paclitaxel-coated balloons and on devices used for stenosis treatment. Meeting directors will have an “Amazing Interventions” contest for junior doctors performing endovascular procedures in vascular access. The best 5 most interesting cases will get a free registration to the meeting together with all the expenses needed for traveling and accommodation covered. EVA Meeting welcomes this year a collaboration with 3 other major congresses. The CiDA (Controversies in Dialysis Access) congress from the United States, the DASy (Dialysis Access synergy) congress by the SoDAS (Society of Dialysis Access Specialists) from the Asia-Pacific region and the PAIRS (Pan-Arabic Interventional Radiology Society) congress from the Middle East. There will be three 45-minute “@EVA” sessions dedicated to these congresses.

DAY 1Friday, June 24th
08.00-08.15Arrival-Registration
08.16-08.23 Welcome Introduction
08.24-09.04What is New and Interesting in Vascular Access
The Nephrologist’s view
The Vascular Surgeon’s view
The Interventional Radiologist’s view
Unmet Needs
Discussion
09.05-09.55 Trial Updates
The Ellipsys Vascular Access System Post-Market Surveillance Study
The WAVE GLOBAL and CONNECT AV Post-Market Studies
The EVA DROP Study
The IPACT AV Study
The SAVE Trial
The ABISS Trial
The VOLA study
Discussion
09.56-10.41 Company Symposium
10.42-11.02 Coffee Break
11.03-11.33 Kidney Transplantation
Global Overview Unmet Needs
Artificial Kidneys and xenotransplantation
Kidney Transplantation and Remaining Vascular Access
Discussion
11.34-12.49Percutaneous AVF Creation [Live Ultrasound Screening]
Patient Selection
Which Questions Have Been Answered Regarding EndoAVF Based on the Evidence so far
What is Still Missing Regarding EndoAVF Based on the Evidence so far
Natural History of a RF-Based EndoAVF (case)
Natural History of a Thermal-Based EndoAVF (case)
Percutaneous Vs. Surgical AVF
Problems in Establishing an Algorithm
Discussion
12.50-13.20CiDA @ EVA "Last Options and New Beginnings"
Moderator-Presenter
Panel:
13.21-14.06 Company Symposium
14.07-14.47 Lunch Break
14.48-15.33Amazing Interventions Competition
Case 1
Case 2
Case 3
Case 4
Case 5
Discussion
15.34-16.14The “Arch” [Live Case]
Anatomical Considerations
ASDIN White Paper on the Management of Cephalic Arch Stenosis
To “COVER” or not to “COVER” stent
The Vascular surgeon’s view
Discussion
16.15-16.43Paclitaxel-Coated Balloon Controversy
There is Homogeneity of Data in Vascular Access and Data Should be Pooled
There is heterogeneity of Data in Vascular Access and Data Should not be Pooled
Discussion
16.44-17.29Company Symposium
17.30-18.00 PAIRS @ EVA
Moderator-Presenter
Panel:
 
DAY 2Saturday, June 25th
08.00-08.40Out of the Box
Radiological Costo-Clavicular Bypass
Inside-Out Approach
Sharp Recanalization Technique
Outflow Veins
Discussion
08.41-09.41 The Way Ahead
Sirolimus. A Novel Drug Coating for DCBs in AV Access?
Omics of Central Venous Stenosis in ESKD
Wearables. Next Level of Surveillance?
Artificial Vessels as an Option for AV Access Creation
Home Dialysis
Dialysis Access Maturation. Is There a Way Ahead?
Percutaneous AVF creation. New player in the game?
Discussion
09.42-10.12SoDAS @ EVA
Moderator-Presenter
Panel:
10.13-10.58 Company Symposium
10.59-11.19 Coffee Break
11.20-12.05Failing to Treat the Failing Vascular Access
Case 1
Case 2
Case 3
Case 4
Case 5
Discussion
12.06-12.51 Declotting Opportunities in the Spotlight [Live Case]
Mechanical Thrombectomy
LAB Thrombectomy
Thrombolytic Agents. Do they play a role?
Surgical Thrombectomy
12.52-13.32 Company Symposium
13.33-14.13Dialysis Vascular Access. Clinical Overview
Clinical Examination. Tips & Tricks
Which Imaging Modality & When
Clinical Evaluation of Dysfunctional Dialysis Access
Clinical Disasters
Discussion
14.14-14.54 Lunch Break
14.55-15.40 Guidelines Updates on Vascular Access Treatment
ERA-EDTA
K-DOQI
A UK Expert Consensus Approach for Managing Symptomatic AVF Stenosis
There is Consensus Between Guidelines
There is No Consensus Between Guidelines
Discussion
15.41-16.26Imaging in Hemodialysis
Non-Contrast Enhanced MRA. A New “Healthy” Tool?
Intra-Vascular Ultrasound in AV access. Advantages and Limitations
Ultrasound Will Give You All the Details You Need
Digital Subtraction Angiography. Can it Stand Alone?
Discussion
16.27-17.07Vascular Access Stenosis Treatment Controversy
What did Covered Stents Offered to Treatment
Paclitaxel-Coated Balloons. Still Debatable?
High-Pressure Balloons Make all the Difference
It’s all About Sheaths, Wires and Catheters
Discussion
17.08-18.00 Central Venous Catheters
CVC related stenosis. How Common, How to Treat
Tricks are in the “Tips”?
Antibiotics. Chemoprophylaxis and Infection Treatment
Last Option CVC Placement
18.00-19.00Editor Writing Club

FILES